Baldwin Wealth Partners LLC MA Boosts Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Baldwin Wealth Partners LLC MA increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 14.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 113,719 shares of the medical device company’s stock after buying an additional 13,926 shares during the quarter. Baldwin Wealth Partners LLC MA’s holdings in Cooper Companies were worth $10,454,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently added to or reduced their stakes in the company. Victory Capital Management Inc. increased its position in Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after acquiring an additional 737,726 shares during the period. Franklin Resources Inc. increased its holdings in shares of Cooper Companies by 194.0% in the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after purchasing an additional 32,260 shares during the period. Principal Financial Group Inc. raised its stake in shares of Cooper Companies by 6.6% during the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock worth $26,295,000 after purchasing an additional 14,687 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after purchasing an additional 573,908 shares during the period. Finally, Bank of Montreal Can grew its position in Cooper Companies by 51.4% in the 3rd quarter. Bank of Montreal Can now owns 326,520 shares of the medical device company’s stock valued at $35,845,000 after buying an additional 110,878 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

COO has been the subject of a number of analyst reports. Wells Fargo & Company upped their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Citigroup cut their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Morgan Stanley cut their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Finally, StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Trading Up 1.9 %

NASDAQ:COO opened at $99.57 on Monday. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a fifty day simple moving average of $95.95 and a 200-day simple moving average of $99.42. The company has a market capitalization of $19.87 billion, a PE ratio of 50.99, a price-to-earnings-growth ratio of 2.41 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies’s revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.87 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.